Trial intelligence / Profile preview

Lormetazepam Injection for Pre-regional Anesthesia Sedation

CTR20232320Phase 3Completed

Sponsor
Huatai Chenguang Pharmaceutical
Start
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of lormetazepam in Procedural anxiety, preoperative anxiety, sponsored by Huatai Chenguang Pharmaceutical. Started Aug 2023; status: completed.

02

Drugs

lormetazepam
03

Conditions

Procedural anxietypreoperative anxiety

Beyond the preview

Go deeper on CTR20232320.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20232320.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call